<DOC>
	<DOCNO>NCT01595932</DOCNO>
	<brief_summary>The aim study evaluate efficacy tolerability α-galactosidase pediatric patient predominant gas-related symptom .</brief_summary>
	<brief_title>Efficacy Tolerability α-galactosidase Treating Gas-related Symptoms Children</brief_title>
	<detailed_description>Most patient functional gastrointestinal disorder complain gas-related symptom negatively affect quality life , even pediatric age . Dietary life-style change , administration simethicone , activate charcoal probiotic may reduce intestinal gas often result unsatisfactory . Literature show α-galactosidase effective reduce gas production relate symptom adult .</detailed_description>
	<criteria>pediatric outpatient gasrelated disturbance least per week last 12 week . suspect episodes hypersensitivity allergy ; chronic organic disorder ( clinical history , physical examination , laboratory test ) ; use drug affect GI motility previous 4 week ; inability parent comprehend full nature purpose study unwillingness cooperate Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>irritable bowel syndrome ( IBS )</keyword>
	<keyword>bloating</keyword>
	<keyword>abdominal distension</keyword>
	<keyword>flatulence</keyword>
	<keyword>α-Galactosidase</keyword>
</DOC>